We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Becton Dickinson and Company | NYSE:BDX | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -5.67 | -2.36% | 234.68 | 242.29 | 234.13 | 238.77 | 1,722,137 | 01:00:00 |
From May 2022 to May 2024
By Connor Hart
Becton Dickinson & Co. on Thursday said profit fell in its third quarter, as spinoff- and acquisition-related costs affected the company's bottom line.
The medical-technology company said net income fell to $360 million, or $1.18 a share, from $525 million, or $1.72 a share, in the previous year.
Adjusted for costs such as acquisition-related charges and amortization, per-share earnings were $2.66. Analysts polled by FactSet had been expecting adjusted per-share earnings of $2.55.
The Franklin Lakes, N.J.-based company said revenue for the quarter ended June 30 edged higher to $4.64 billion from $4.61 billion. Analysts had been expecting revenue of $4.5 billion, according to FactSet.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
August 04, 2022 07:07 ET (11:07 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Becton Dickinson Chart |
1 Month Becton Dickinson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
